• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Nat Biotechnol. Author manuscript; available in PMC Jun 23, 2010.
Published in final edited form as:
PMCID: PMC2891235
NIHMSID: NIHMS196353

Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture

Abstract

We have modified the biotin switch assay for protein S-nitrosothiols (SNOs), using resin-assisted capture (SNO-RAC). Compared with existing methodologies, SNO-RAC requires fewer steps, detects high-mass S-nitrosylated proteins more efficiently, and facilitates identification and quantification of S-nitrosylated sites by mass spectrometry. When combined with iTRAQ labeling, SNO-RAC revealed that intracellular proteins may undergo rapid denitrosylation on a global scale. This methodology is readily adapted to analyzing diverse cysteine-based protein modifications, including S-acylation.

Nitric oxide exerts a ubiquitous influence on cellular signaling, in large part by means of S-nitrosylation/denitrosylation of protein cysteine residues1. It is also increasingly apparent that dysregulated S-nitrosylation may play a causal role in a spectrum of human diseases2, 3, 4. The biotin switch technique (BST)5 is the most commonly used method to detect cellular S-nitrosylation and has greatly advanced the field5, 6, 7, 8. It comprises three principal steps: blocking free thiols on cysteines by S-methylthiolation with a reactive thiosulfonate, converting SNOs to thiols with ascorbate, and labeling nascent thiols with biotin-HPDP (N-(6-(Biotinamido)hexyl)-3′-(2′-pyridyldithio)-propionamide). The degree of biotinylation (and hence S-nitrosylation) is determined by either anti-biotin immunoblotting or streptavidin pulldown followed by immunoblotting for the protein(s) of interest. The BST is, however, labor intensive and has relatively low throughput. Our simpler assay, SNO-RAC (Fig. 1a and Supplementary Methods online) uses a thiol-reactive resin instead of thiol-reactive biotin, thus combining the obligatory ‘labeling’ and ‘pulldown’ steps in the BST. As SNO-RAC results in a covalent disulfide linkage between the SNO site and resin, it is amenable to ‘on-resin’ trypsinization and peptide labeling, which subserve mass spectrometric methodologies.

Figure 1
Analysis of protein S-nitrosylation by SNO-RAC

Side-by-side comparison of the BST and SNO-RAC approaches using human embryonic kidney (HEK293) cells treated with S-nitrosocysteine (CysNO) and performed on individual (Fig. 1b) and total (Fig. 1c) SNO-proteins suggests superior sensitivity of SNO-RAC relative to the BST for proteins larger than ~100 kDa (Fig. 1c), perhaps due to the fewer precipitation steps required by SNO-RAC versus the BST. Proteins uniquely detected by SNO-RAC and identified by mass spectrometry (MS) are listed in Supplementary Table 1 online. Improved sensitivity for high-mass proteins (and at least some lower mass species) was also evident in THP-1 monocytes (Supplementary Fig. 1 online) and with the S-nitrosylated ryanodine receptor, which has a mass of 565 kDa (Fig. 1d). The BST methodology has been recently adapted to assay S-acylated proteins (ascorbate is substituted with hydroxylamine9), and an analogous RAC-based strategy (Acyl-RAC) showed robust results (Fig. 1e). Thus, overall, SNO-RAC appears to be more sensitive than the BST for high mass proteins, and at least as sensitive as the BST for proteins smaller than 100 kDa. Moreover, it shows general applicability in analyses of post-translational modifications of cysteines.

To further gauge the suitability of SNO-RAC for detecting endogenous SNO-proteins, we assayed S-nitrosylation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a SNO-based cell-death effector10, in RAW264.7 macrophages after stimulation of inducible nitric oxide synthase with cytokines (Fig. 1f). Assay specificity was confirmed by ultraviolet ‘pre-photolysis’ (Fig. 1f), which eliminates SNO but not other cysteine-based redox modifications11. SNO-RAC analysis of cytokine-stimulated macrophages suggested the presence of multiple S-nitrosylated proteins, including a novel SNO-protein at 22 kDa, which was identified by mass spectrometry (MS) as peroxiredoxin-1 (Prx1) (Fig. 1g and Supplementary Fig. 2 online). S-nitrosylation of Prx1 by inducible nitric oxide synthase in RAW264.7 and HEK293 cells was confirmed by SNO-RAC with western blotting (Fig. 1h–i).

To assess the ability of SNO-RAC to identify SNO sites, purified GAPDH treated with CysNO was compared with untreated protein after SNO-RAC, on-resin digestion with trypsin and analysis by matrix-assisted laser desorption ionization-(MALDI)-MS (Supplementary Fig. 3 online). Four cysteine-containing peptides corresponding to GAPDH SNO-sites were identified. An analogous experiment was performed on CysNO-treated macrophages (Supplementary Fig. 4 and Supplementary Table 2 online), with confirmation obtained by western blotting (Supplementary Fig. 5 online). We next attempted to characterize the full complement of S-nitrosylated proteins in CysNO-treated Escherichia coli by isotopically encoded SNO-RAC; after on-resin proteolysis, the samples were acetylated with either H6- (control) or D6- (CysNO-treated) acetic anhydride, which resulted in a mass shift of 3.03 Da per primary amine. This approach revealed 44 novel SNO sites in E. coli (Supplementary Fig. 6 and Supplementary Tables 3 and 4 online). Importantly, all novel identifications contained the D3-acetylated mass, whereas an H3-acetylated peptide was not found.

Enzymatic pathways for protein denitrosylation have been recently identified12, 13, but the extent to which they influence SNO-based signaling or stress is unknown. SNO-RAC was used to examine the dynamics of S-nitrosylation/denitrosylation in intact cells. Most SNO proteins underwent rapid denitrosylation after CysNO treatment (Fig. 2a). To quantify relative rates of SNO-site denitrosylation, SNO peptides derived from untreated cells or those harvested 10, 30 and 50 min after CysNO exposure, were labeled on-resin with isobaric tags for relative and absolute quantification (iTRAQ; with 114, 115, 116 and 117 amu ‘reporter ions’, respectively)14, allowing for facile multiplexing with liquid chromatography–tandem MS. Kinetic analysis revealed varying rates of SNO turnover among individual sites of protein S-nitrosylation. A typical iTRAQ pattern is exemplified by the Cys166-containing ERK2 peptide, which exhibited fairly rapid denitrosylation, as revealed by decreasing reporter ion intensities (Fig. 2b). The kinetics of S-nitrosylation/denitrosylation of four representative SNO sites—two relatively unstable (Cys347 of -tubulin and Cys166 of ERK2) and two relatively stable (Cys162 of PCNA and Cys86 of UbcH7) (Fig. 2c)—were verified at the protein level (Fig. 2d). Interestingly, S-nitrosylated -tubulin and ERK2 have been shown to be resistant to denitrosylation by glutathione in vitro7, suggesting that multiple denitrosylases may be operative in cells7, 12, 13.

Figure 2
iTRAQ-coupled SNO-RAC demonstrates proteome-wide (global) denitrosylation

Proteome-wide analysis by iTRAQ-coupled SNO-RAC confirms the global occurrence of denitrosylation (Fig. 2e and Supplementary Table 5 online): nearly all SNO sites showed intense reporter ions at 115 amu, followed by progressive decay over time. Collectively, these results support the notion that denitrosylation is a major determinant of steady-state SNO levels. SNO-RAC and its modifications represent a highly versatile methodology that should facilitate the study of the diverse post-translational modifications of cysteine residues that may be designated the cysteome.

Supplementary Material

Suppl Material

Supplementary Table 4

Supplementary Table 5

Supplementary Table 6

Acknowledgments

We thank S. Nimkar (Applied Biosystems) for providing iTRAQ reagents, and Q. Sun, K. Ozawa, A. Hausladen and D. Hess for expert advice. This work was supported by National Institutes of Health grants U19-ES012496, P01-HL075443, HL075443 and HL059130.

Footnotes

Accession numbers

PRIDE database: MS data have been deposited with accession codes 9735–9737, 9748.

References

1. Hess DT, et al. Nat Rev Mol Cell Biol. 2005;6:150–166. [PubMed]
2. Cho DH, et al. Science. 2009;324:102–105. [PMC free article] [PubMed]
3. Lim KH, et al. Nature. 2008;452:646–649. [PMC free article] [PubMed]
4. Foster MW, et al. Trends Mol Med. 2003;9:160–168. [PubMed]
5. Jaffrey SR, et al. Nat Cell Biol. 2001;3:193–197. [PubMed]
6. Greco TM, et al. Proc Natl Acad Sci USA. 2006;103:7420–7425. [PMC free article] [PubMed]
7. Paige JS, et al. Chem Biol. 2008;15:1307–1316. [PMC free article] [PubMed]
8. Hao G, et al. Proc Natl Acad Sci USA. 2006;103:1012–1017. [PMC free article] [PubMed]
9. Roth AF, et al. Cell. 2006;125:1003–1013. [PMC free article] [PubMed]
10. Hara MR, et al. Nat Cell Biol. 2005;7:665–674. [PubMed]
11. Forrester MT, et al. J Biol Chem. 2007;282:13977–13983. [PubMed]
12. Benhar M, et al. Science. 2008;320:1050–1054. [PMC free article] [PubMed]
13. Liu L, et al. Cell. 2004;116:617–628. [PubMed]Ross PL, et al. Mol Cell Proteomics. 2004;3:1154–1169. [PubMed]
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...